These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 702336)

  • 21. Dopamine preferentially stimulates postsynaptic alpha 2-adrenoceptors in the femoral vascular bed, but alpha 1-adrenoceptors in the renal vascular bed of the anaesthetised dog.
    Duval N; Hicks PE; Langer SZ
    Eur J Pharmacol; 1985 Feb; 108(3):265-72. PubMed ID: 2859210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390.
    Goldberg LI; Glock D; Kohli JD; Barnett A
    Hypertension; 1984; 6(2 Pt 2):I25-30. PubMed ID: 6144634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
    Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M
    J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of dopamine-4-O-sulfate.
    Ackerman DM; Hieble JP; Sarau HM; Jain TC
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):241-8. PubMed ID: 6712357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine vascular actions of N-substituted derivatives of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN).
    Kohli JD; Goldberg LI; Nichols DE
    Eur J Pharmacol; 1979 Jun; 56(1-2):39-44. PubMed ID: 467513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation.
    Giraud GD; MacCannell KL
    J Pharmacol Exp Ther; 1984 Jul; 230(1):214-20. PubMed ID: 6747827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dopamine on intestinal vessels in anesthetized dogs.
    van Kesteren RG; van Alphen MM; Charbon GA
    Circ Shock; 1988 May; 25(1):41-51. PubMed ID: 3402051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine.
    Lass NA; Glock D; Goldberg LI
    Circulation; 1988 Nov; 78(5 Pt 1):1310-5. PubMed ID: 2902941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
    Hom GJ; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.
    Polakowski JS; Segreti JA; Cox BF; Hsieh GC; Kolasa T; Moreland RB; Brioni JD
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):837-41. PubMed ID: 15659045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution.
    Kohli JD; Goldberg LI; McDermed JD
    Eur J Pharmacol; 1982 Jul; 81(2):293-9. PubMed ID: 6126371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational requirements for dopamine-induced vasodilation.
    Volkman PH; Kohli JD; Goldberg LI; Cannon JG; Lee T
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3602-6. PubMed ID: 269416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration in ocular function induced by phenylethylamine analogs of dopamine.
    Potter DE; Burke JA; Chang FW
    Curr Eye Res; 1984 Jun; 3(6):851-9. PubMed ID: 6329603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
    Satoh Y; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1989 Oct; 251(1):253-7. PubMed ID: 2571718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal hemodynamics in hemorrhagic hypotension: studies on the effects of pre- and postjunctional dopamine receptor agonists.
    Hamed AT; Ginos JZ; Ekas RD; Jandhyala BS; Lokhandwala MF
    J Cardiovasc Pharmacol; 1983; 5(2):207-12. PubMed ID: 6188891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
    Zhao RR; Wang PH; Zhang WF; Fennell WH
    Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.